JNJ - Company ID 0000200406
The table below shows JOHNSON & JOHNSON's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $24.06B | $23.99B | $23.74B | $21.89B | $22.47B | $22.45B |
| Cost of revenue | $8.11B | $7.30B | $7.63B | $7.36B | $6.96B | $6.87B |
| Gross profit | $15.96B | $16.69B | $16.11B | $14.54B | $15.51B | $15.58B |
| R&D | - | - | - | - | - | - |
JOHNSON & JOHNSON reported annual revenue of $94.19B for fiscal year 2025. That is up 6.0% from $88.82B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $71.89B (FY 2017) to $94.19B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $6.03B |
| $5.92B |
| $5.89B |
| $5.11B |
| $5.48B |
| $5.68B |
| Operating income | - | - | - | - | - | - |
| Income tax | $755.00M | $2.34B | $954.00M | $2.63B | $644.00M | $1.06B |
| Net income | $5.24B | $5.15B | $5.54B | $11.00B | $2.69B | $4.69B |
| EPS (diluted) | $2.14 | $2.12 | $2.29 | $4.54 | $1.11 | $1.93 |